What did @hydromedspa actually say?
The creator, identifying as Dr. Terrips Jeffress of Hydro Med Spa, is pushing back on a common fear: that starting testosterone replacement therapy (TRT) means you're committed to it permanently. His core argument is that "the minute you inject yourself with testosterone, you don't all of a sudden shut down your pituitary gland." He also distinguishes between men with clinically low testosterone and younger guys using testosterone supraphysiologically for muscle gains, arguing the "on it for life" narrative comes more from the latter group. He mentions post-cycle therapy (PCT) and enclomiphene as tools to help restore natural production after stopping.
The take is framed as reassurance for men hesitating to start TRT. That framing has real consequences for how people interpret the risks.
Does the science back this up?
Partially, yes, but the picture is more complicated than a TikTok explanation can hold. The hypothalamic-pituitary-gonadal (HPG) axis does suppress when exogenous testosterone is introduced, and recovery is possible, but it is not guaranteed or quick.
A 2020 review by Rastrelli, Corona, and Maggi in the journal Best Practice and Research Clinical Endocrinology and Metabolism confirmed that HPG axis suppression from exogenous testosterone is real and dose-dependent. Recovery of endogenous testosterone production after stopping TRT is possible in most men, but duration of suppression, age, and baseline testicular function all affect how well and how fast the axis rebounds. A 2013 study by Liu et al. in Journal of Clinical Endocrinology and Metabolism found that sperm production recovery after testosterone use could take anywhere from a few months to over two years. That is not the same as "you won't be shut down forever," but it is also not "you're stuck on it for life." The truth lives uncomfortably in between.
What did they get wrong (or right)?
He is right that TRT is not automatically a lifetime commitment, and that framing deserves credit because it is a genuine barrier stopping some hypogonadal men from seeking treatment they may actually need. The distinction he draws between clinical TRT and anabolic steroid use is also directionally correct: men running 500mg of testosterone weekly for bodybuilding face a very different suppression profile than someone on 100mg weekly to reach mid-normal physiological levels.
Where he undersells the complexity is in suggesting that starting TRT casually does not carry real suppression risk from day one. It does. The HPG axis begins suppressing relatively quickly after exogenous testosterone is introduced, even at therapeutic doses. Tanrikut and Schlegel (2007, Urology) documented measurable azoospermia or severe oligospermia in men on therapeutic TRT. He also mentions that "most guys" with low testosterone "want to be on it for the rest of their lives," which is probably accurate based on clinical experience, but packaging that as reassurance rather than a decision point feels like it glosses over the weight of that choice.
What should you actually know?
If you are considering TRT, here is what the research actually supports. HPG axis suppression begins with the first dose. Recovery after stopping is likely but not guaranteed, and it is slower the longer you have been on therapy. Enclomiphene, which the creator mentions, does have legitimate evidence as a tool to stimulate LH and FSH while maintaining or restoring testicular function. A 2019 trial by Wiehle et al. in Therapeutic Advances in Urology found enclomiphene raised testosterone while preserving sperm parameters, which is a meaningful distinction from traditional TRT.
If fertility matters to you now or in the future, have that conversation with a physician before starting, not after. PCT protocols borrowed from the bodybuilding world have variable evidence in clinical TRT patients, and they should not be treated as a reliable off-ramp for everyone.
- Duration of TRT affects how hard it is to recover endogenous production.
- Age and baseline testicular reserve matter significantly.
- Enclomiphene is a legitimate clinical option, not just a PCT supplement.
- Stopping TRT abruptly without a plan is not the same as a medically supervised taper or stimulation protocol.
The creator's overall message, that TRT is not a one-way door, is defensible. The execution leaves out enough nuance to warrant caution before anyone takes it as personal medical guidance.